Spanish-speaking patients can opt to use the Dexcom G6 app in their preferred language, eliminating a language barrier for optimal care.

The Signos Glucose Monitoring System is a mobile device application that receives data from an over-the-counter integrated continuous glucose monitor, the Dexcom Stelo Biosensor. Paired together, the ...

Dexcom, known to people with diabetes for making continuous glucose monitoring (CGM) systems, has handed a valuable tool to developers of compatible diabetes software with the launch of a public ...

ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible ...

After a successful launch last year, glucose monitoring company Dexcom is reupping its name, image, likeness (NIL) program for college athletes with diabetes. Known as Dexcom U, the program launched ...

UnitedHealthcare has built a Type 2 diabetes management program around Dexcom’s devices. The initiative will provide certain UnitedHealth members with Dexcom’s continuous glucose monitoring ...

Additionally, Dexcom is likely to benefit from two other sources of growth: the adoption of Dexcom One in Europe for type 2 patients on intensive insulin, and a new monitor intended for type 2 ...

SAN DIEGO, July 17, 2025--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of Dexcom U, the company’s one-of-a-kind NIL (Name ...

DexCom sent its application for clearance of the G7 device to U.S. regulators in late 2021, but some last-minute changes to the associated smartphone application have held up the process.

Dexcom provides more choice to users by launching Spanish-language capabilities for its mobile app for the best-selling real-time CGM in the world Spanish-speaking patients can opt to use the ...